fluorobenzenes has been researched along with Carotid Artery Narrowing in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, I; Bertolotto, M; Dallegri, F; Fabre, M; Galan, K; Lenglet, S; Mach, F; Montecucco, F; Nencioni, A; Palombo, D; Pane, B; Pelli, G; Pende, A; Python, M; Quercioli, A; Spinella, G; Vuilleumier, N | 1 |
| Balbarini, A; Conte, L; Cortese, B; De Carlo, M; Misuraca, L; Pennesi, M; Petronio, AS; Pitì, A | 1 |
| Biacchi, D; Bononi, M; Borrelli, V; Di Marzo, L; Sapienza, P; Sterpetti, AV; Tartaglia, E; Venturini, L | 1 |
| Hammer, HB; Hisdal, J; Holme, I; Ikdahl, E; Kitas, GD; Kvien, TK; Olsen, IC; Pedersen, TR; Rollefstad, S; Semb, AG; Smerud, KT | 1 |
| Arai, H; Daida, H; Hatsukami, TS; Hattori, N; Hirose, T; Ikeda, F; Kawamori, R; Maehara, T; Miyauchi, K; Ohishi, H; Sase, K; Suzuki, M; Takaya, N; Urabe, T; Yamamoto, M; Yoshida, K; Yuan, C | 1 |
| Freedman, B; Kuan, WP; Lee, KK; Lee, VW; Li, EK; Li, M; Li, TK; Shang, Q; Tam, LS; Tomlinson, B; Tseung, L; Yip, GW; Yu, CM | 1 |
| Bots, ML; Crouse, JR; Evans, GW; Grobbee, DE; O'Leary, DH; Palmer, MK; Raichlen, JS; Riley, WA | 2 |
6 trial(s) available for fluorobenzenes and Carotid Artery Narrowing
| Article | Year |
|---|---|
Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Carotid Artery, Common; Carotid Stenosis; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Middle Aged; Preoperative Care; Prospective Studies; Prosthesis Design; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Stents; Sulfonamides; Treatment Outcome; Young Adult | 2014 |
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Topics: Acute Coronary Syndrome; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Carotid Stenosis; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Spondylitis, Ankylosing; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2015 |
Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.
Topics: Angiography; Carotid Stenosis; Cholesterol, LDL; Dose-Response Relationship, Drug; Endpoint Determination; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Longitudinal Studies; Magnetic Resonance Imaging; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tunica Intima; Tunica Media | 2009 |
Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
Topics: Apolipoproteins B; Arthritis, Rheumatoid; Atherosclerosis; Carotid Intima-Media Thickness; Carotid Stenosis; Cholesterol; Disease Progression; Double-Blind Method; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Treatment Outcome; Vascular Stiffness | 2011 |
Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Topics: Arteriosclerosis; C-Reactive Protein; Carotid Stenosis; Double-Blind Method; Drug Administration Schedule; Fluorobenzenes; Humans; Lipid Metabolism; Lipids; Multicenter Studies as Topic; Patient Selection; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.
Topics: Age Factors; Aged; Body Mass Index; Carotid Artery, Common; Carotid Stenosis; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Europe; Female; Fluorobenzenes; Humans; Male; Middle Aged; Multivariate Analysis; Probability; Prognosis; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Severity of Illness Index; Sex Factors; Sulfonamides; Survival Analysis; Tunica Intima; Tunica Media; United States | 2007 |
2 other study(ies) available for fluorobenzenes and Carotid Artery Narrowing
| Article | Year |
|---|---|
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.
Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Stenosis; Cohort Studies; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 9; Middle Aged; Neutrophil Activation; Neutrophils; NF-kappa B; Osteopontin; Osteoprotegerin; Pyrimidines; Pyrroles; RANK Ligand; Risk Factors; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2014 |
Statins reduce levels of metalloproteinases in patients with carotid occlusive disease.
Topics: Aged; Angiography; Asymptomatic Diseases; Carotid Stenosis; Disease Progression; Drug Monitoring; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metalloproteases; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Color | 2014 |